Back Other STDs

Other STDs

IDWeek 2016: Rapid Emergence of Drug-Resistant Gonorrhea Seen in Ohio

Routine surveillance in southern Ohio has detected a steep increase in gonorrhea showing resistance to ciprofloxacin or reduced susceptibility to azithromycin, according to a presentation at IDWeek last week in New Orleans. Azithromycin is one of the 2 drugs in the sole recommended gonorrhea treatment regimen in the U.S., but no resistance to ceftriaxone, the other drug in that regimen, was seen.

alt

Read more:

Sexually Transmitted Disease Rates Hit New Highs, CDC Report Says

Cases of chlamydia, gonorrhea, and syphilis are at their highest level ever -- exceeding last year's record levels -- even as STD prevention, testing, and treatment services have eroded, according to the latest Sexually Transmitted Disease Surveillance report, released this week by the Centers for Disease Control and Prevention (CDC). Young people and gay and bisexual men are particularly heavily impacted, and transmission of syphilis from pregnant women to their babies is a growing concern.

alt

Read more:

STD 2016: Growing Threat of Antibiotic-Resistant Gonorrhea in the U.S. and Worldwide

Public health officials in Hawaii have identified the first cluster of gonorrhea cases with reduced susceptibility to both drugs in the current recommended regimen, according to a report at the 2016 STD Prevention Conference taking place this week in Atlanta. While all 7 patients were successfully treated, this cluster underscores the need for new therapies, one of which was presented at the conference.

alt

Read more:

STD 2016: Syphilis Rates Are Rising Among Gay Men, CDC Data Show

New state-level data reveal that syphilis cases continue to rise among gay and bisexual men, with men in the south having the highest rates, according to a presentation at the 2016 STD Prevention Conference last week in Atlanta. A related study found that half of gay and bisexual men in 20 cities were screened for syphilis during the past year, with 11% testing positive.

alt

Read more:

ASM Microbe 2016: Novel Immune Therapy GEN-003 Improves Genital Herpes

GEN-003, a therapeutic vaccine containing recombinant herpes simplex virus (HSV) antigens, showed significant antiviral activity lasting up to a year and reduced the number of genital herpes lesions and days with recurrences, researchers reported this week at the ASM Microbe 2016 meeting in Boston.

alt

Read more: